Cargando…

Service-user efforts to maintain their wellbeing during and after successful withdrawal from antipsychotic medication

BACKGROUND: It is well-known that attempting antipsychotic withdrawal can be a fraught process, with a high risk of relapse that often leads people to resume the medication. Nonetheless, there is a group of people who appear to be able to discontinue successfully. Relatively little is known about ho...

Descripción completa

Detalles Bibliográficos
Autores principales: Larsen-Barr, Miriam, Seymour, Fred
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7970681/
https://www.ncbi.nlm.nih.gov/pubmed/33796264
http://dx.doi.org/10.1177/2045125321989133
_version_ 1783666460222029824
author Larsen-Barr, Miriam
Seymour, Fred
author_facet Larsen-Barr, Miriam
Seymour, Fred
author_sort Larsen-Barr, Miriam
collection PubMed
description BACKGROUND: It is well-known that attempting antipsychotic withdrawal can be a fraught process, with a high risk of relapse that often leads people to resume the medication. Nonetheless, there is a group of people who appear to be able to discontinue successfully. Relatively little is known about how people do this. METHODS: A convenience sample of adults who had stopped taking antipsychotic medication for more than a year were recruited to participate in semi-structured interviews through an anonymous online survey that investigated antipsychotic medication experiences in New Zealand. Thematic analysis explored participant descriptions of their efforts to maintain their wellbeing during and after the withdrawal process. RESULTS: Of the seven women who volunteered to participate, six reported bipolar disorder diagnoses and one reported diagnoses of obsessive compulsive disorder and depression. The women reported successfully discontinuing antipsychotics for 1.25–25 years; six followed a gradual withdrawal method and had support to prepare for and manage this. Participants defined wellbeing in terms of their ability to manage the impact of any difficulties faced rather than their ability to prevent them entirely, and saw this as something that evolved over time. They described managing the process and maintaining their wellbeing afterwards by ‘understanding myself and my needs’, ‘finding what works for me’ and ‘connecting with support’. Sub-themes expand on the way in which they did this. For example, ‘finding what works for me’ included using a tool-box of strategies to flexibly meet their needs, practicing acceptance, drawing on persistence and curiosity and creating positive life experiences. CONCLUSION: This is a small, qualitative study and results should be interpreted with caution. This sample shows it is possible for people who experience mania and psychosis to successfully discontinue antipsychotics and safely manage the impact of any symptoms that emerge as a result of the withdrawal process or other life stressors that arise afterwards. Findings suggest internal resources and systemic factors play a role in the outcomes observed among people who attempt to stop taking antipsychotics and a preoccupation with avoiding relapse may be counterproductive to these efforts. Professionals can play a valuable role in facilitating change.
format Online
Article
Text
id pubmed-7970681
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-79706812021-03-31 Service-user efforts to maintain their wellbeing during and after successful withdrawal from antipsychotic medication Larsen-Barr, Miriam Seymour, Fred Ther Adv Psychopharmacol Discontinuing Psychotropic Medications BACKGROUND: It is well-known that attempting antipsychotic withdrawal can be a fraught process, with a high risk of relapse that often leads people to resume the medication. Nonetheless, there is a group of people who appear to be able to discontinue successfully. Relatively little is known about how people do this. METHODS: A convenience sample of adults who had stopped taking antipsychotic medication for more than a year were recruited to participate in semi-structured interviews through an anonymous online survey that investigated antipsychotic medication experiences in New Zealand. Thematic analysis explored participant descriptions of their efforts to maintain their wellbeing during and after the withdrawal process. RESULTS: Of the seven women who volunteered to participate, six reported bipolar disorder diagnoses and one reported diagnoses of obsessive compulsive disorder and depression. The women reported successfully discontinuing antipsychotics for 1.25–25 years; six followed a gradual withdrawal method and had support to prepare for and manage this. Participants defined wellbeing in terms of their ability to manage the impact of any difficulties faced rather than their ability to prevent them entirely, and saw this as something that evolved over time. They described managing the process and maintaining their wellbeing afterwards by ‘understanding myself and my needs’, ‘finding what works for me’ and ‘connecting with support’. Sub-themes expand on the way in which they did this. For example, ‘finding what works for me’ included using a tool-box of strategies to flexibly meet their needs, practicing acceptance, drawing on persistence and curiosity and creating positive life experiences. CONCLUSION: This is a small, qualitative study and results should be interpreted with caution. This sample shows it is possible for people who experience mania and psychosis to successfully discontinue antipsychotics and safely manage the impact of any symptoms that emerge as a result of the withdrawal process or other life stressors that arise afterwards. Findings suggest internal resources and systemic factors play a role in the outcomes observed among people who attempt to stop taking antipsychotics and a preoccupation with avoiding relapse may be counterproductive to these efforts. Professionals can play a valuable role in facilitating change. SAGE Publications 2021-01-31 /pmc/articles/PMC7970681/ /pubmed/33796264 http://dx.doi.org/10.1177/2045125321989133 Text en © The Author(s), 2021 https://creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access page (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Discontinuing Psychotropic Medications
Larsen-Barr, Miriam
Seymour, Fred
Service-user efforts to maintain their wellbeing during and after successful withdrawal from antipsychotic medication
title Service-user efforts to maintain their wellbeing during and after successful withdrawal from antipsychotic medication
title_full Service-user efforts to maintain their wellbeing during and after successful withdrawal from antipsychotic medication
title_fullStr Service-user efforts to maintain their wellbeing during and after successful withdrawal from antipsychotic medication
title_full_unstemmed Service-user efforts to maintain their wellbeing during and after successful withdrawal from antipsychotic medication
title_short Service-user efforts to maintain their wellbeing during and after successful withdrawal from antipsychotic medication
title_sort service-user efforts to maintain their wellbeing during and after successful withdrawal from antipsychotic medication
topic Discontinuing Psychotropic Medications
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7970681/
https://www.ncbi.nlm.nih.gov/pubmed/33796264
http://dx.doi.org/10.1177/2045125321989133
work_keys_str_mv AT larsenbarrmiriam serviceusereffortstomaintaintheirwellbeingduringandaftersuccessfulwithdrawalfromantipsychoticmedication
AT seymourfred serviceusereffortstomaintaintheirwellbeingduringandaftersuccessfulwithdrawalfromantipsychoticmedication